MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Boston Scientific to Spend $40 Million on Stent Post-Op Campaign

Boston Scientific has dedicated $40 million to a program educating drug-eluting stent patients about the importance of taking blood thinners after their operations, the Boston Globe reports. The company has produced kits that will go to about 700,000 patients a year.

It will also push to have patients counseled about taking blood thinners before they are discharged from the hospital. All this is coming after the controversy over whether drug-eluting stents are more likely to cause blood clots than their bare-metal counterparts. And the program is unveiled a week after two studies questioned whether stents should be used in non-emergency cases at all.  Is this good medicine? Yes. Does the timing make the company look like it's on the defensive? Yes again.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish